INHBE and breast cancer: Blockade of activin signaling by a soluble activin receptor type IIA fusion protein can promote osteoblast-mediated bone formation and inhibit breast cancer bone metastasis in a murine model [25], indicating an important role of activins in bone homeostasis and bone metastasis.